Evidence map›Paper›PMID 27902458›Full record

ArticleOncotarget2017

DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients.

Noemí García-Romero, Josefa Carrión-Navarro, Susana Esteban-Rubio, Elisa Lázaro-Ibáñez, María Peris-Celda, Marta M Alonso, Juan Guzmán-De-Villoria, Carlos Fernández-Carballal, Ana Ortiz de Mendivil, Sara García-Duque and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 152 papers.

0numbers the graph read from it
0cells of the map it votes in
152citing papers in PubMed
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

152 citing papers in PubMed, 266 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Extracellular Vesicles as a Potential Therapy for Stroke.International journal of molecular sciences · 2025
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

92 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Noemí García-RomeroFundación de Investigación HM Hospitales, HM Hospitales, Madrid, Spain.
Josefa Carrión-NavarroFundación de Investigación HM Hospitales, HM Hospitales, Madrid, Spain.
Susana Esteban-RubioFundación de Investigación HM Hospitales, HM Hospitales, Madrid, Spain.
Elisa Lázaro-IbáñezDivision of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
María Peris-CeldaDepartment of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Marta M AlonsoClínica Universidad de Navarra, CIMA, Pamplona, Spain.
Juan Guzmán-De-VilloriaServicio de Radiodiagnóstico, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Carlos Fernández-CarballalServicio de Neurocirugía, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Ana Ortiz de MendivilFundación de Investigación HM Hospitales, HM Hospitales, Madrid, Spain.
Sara García-DuqueFundación de Investigación HM Hospitales, HM Hospitales, Madrid, Spain.
Carmen Escobedo-LuceaDivision of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
Ricardo Prat-AcínDepartamento de Neurocirugía, Hospital Universitario la Fe, Valencia, Spain.
Cristóbal Belda-IniestaFundación de Investigación HM Hospitales, HM Hospitales, Madrid, Spain.
Angel Ayuso-SacidoFundación de Investigación HM Hospitales, HM Hospitales, Madrid, Spain.
HM Hospitales · ESHospital General Universitario Gregorio Marañón · ESUniversidad San Pablo CEU · ESUniversity of Helsinki · FIClinica Universidad de Navarra · ESHospital Universitari i Politècnic La Fe · ESNeurological Surgery · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor-cell-secreted extracellular vesicles (EVs) can cross the disrupted blood-brain barrier (BBB) into the bloodstream. However, in certain gliomas, the BBB remains intact, which might limit EVs release. To evaluate the ability of tumor-derived EVs to cross the BBB, we used an orthotopic xenotransplant mouse model of human glioma-cancer stem cells featuring an intact BBB. We demonstrated that all types of tumor cells-derived EVs-apoptotic bodies, shedding microvesicles and exosomes-cross the intact BBB and can be detected in the peripheral blood, which provides a minimally invasive method for their detection compared to liquid biopsies obtained from cerebrospinal fluid (CSF). Furthermore, these EVs can be readily distinguished from total murine EVs, since they carry human-specific DNA sequences relevant for GBM biology. In a small cohort of glioma patients, we finally demonstrated that peripheral blood EVs cargo can be successfully used to detect the presence of IDH1G395A, an essential biomarker in the current management of human glioma.

Indexed as

AdultAnimalsBase SequenceBlood-Brain BarrierBrain NeoplasmsDisease Models, AnimalDNA, NeoplasmExtracellular VesiclesFemaleGliomaHumansMaleMiceMice, NudeMiddle AgedDNA, Neoplasmbiomarkersblood-brain barrierbrain tumorsextracellular vesicles

Identifiers

PMID27902458
PMCPMC5352065
OpenAlexW2554880605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.